Split History
ETFs Holding JUNO »    JUNO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Juno Therapeutics is a biopharmaceutical company focused on the treatment of cancer. Co. is developing cell-based cancer immunotherapies based on its chimeric antigen receptor (CAR) and high-affinity T cell receptor (TCR) technologies to genetically engineer T cells to recognize and kill cancer cells. Co.'s CAR and TCR technologies alter T cells ex vivo, so that the T cells can recognize specific proteins on the surface or inside cancer cells or other diseased cells in order to kill those diseased cells. Co.'s product candidates, JCAR017, JCAR014, and JCAR015 utilize CAR technology to target CD19, a protein expressed on the surface of almost all B cell leukemias and lymphomas. According to our JUNO split history records, JUNO has had 1 split.
JUNO split history picture
JUNO (JUNO) has 1 split in our JUNO split history database. The split for JUNO took place on June 09, 1992. This was a 2 for 1 split, meaning for each share of JUNO owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as JUNO splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the JUNO split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into JUNO shares, starting with a $10,000 purchase of JUNO, presented on a split-history-adjusted basis factoring in the complete JUNO split history. JUNO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/29/2014
End date: 03/06/2018
Start price/share: $54.21
End price/share: $86.96
Dividends collected/share: $0.00
Total return: 60.41%
Average Annual Total Return: 15.99%
Starting investment: $10,000.00
Ending investment: $16,042.18
Years: 3.19
Date Ratio
06/09/19922 for 1
JUNO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

KALV Split History
KBIO Split History
KIDS Split History
KOOL Split History
LCAV Split History
LCI Split History
LH Split History
LIFE Split History
LJPC Split History
LLY Split History

Xenetic Biosciences, Inc. (XBIO)
Yuma Energy, Inc. (YUMA)
Avinger, Inc. (AVGR)
Sonoma Pharmaceuticals, Inc. (SOMA)
Hudson Global, Inc. (HSON)
Jaguar Health, Inc. (JAGX)
Cesca Therapeutics Inc. (KOOL)
Northern Technologies International Corporation (NTIC)
Digirad Corporation (DRAD)
Hemispherx Biopharma, Inc. (HEB)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

JUNO Insider Buying

JUNO Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.